DEEPSEEK

DeepSeek is an AI company and a family of large language models based in Hangzhou, China. It was founded in 2023 and funded by High-Flyer, a well - known quantitative asset management giant. DeepSeek is dedicated to developing advanced large language models and related technologies. It has released several models, including DeepSeek LLM, DeepSeek Coder, DeepSeekMath, and DeepSeek - VL. The latest version, DeepSeek - V3, which was launched in December 2024, has 67.1 billion parameters and was trained on a dataset of 14.8 trillion tokens. It uses FP8 training and open - sources the native FP8 weights. Benchmark tests show that it outperforms Llama 3.1 and Qwen 2.5 while matching GPT - 4O and Claude 3.5 Sonnet. In addition, DeepSeek - R1, which was officially released on January 20, 2025, performs on a par with OpenAI O1 in terms of mathematics, code, and natural language reasoning tasks. DeepSeek's models have a wide range of applications, such as chat and coding scenarios, multilingual automatic translation, image generation, and AI painting. With their high performance and low cost, DeepSeek's models have quickly gained popularity. For example, on February 2, 2025, the DeepSeek app climbed to the top of the download charts in 140 countries on the Apple App Store and also topped the Android Play Store in the United States

deepseek

NVIDIA NIM Enhances Curation of Biological Insights with AI

NVIDIA NIM, in collaboration with CytoReason, leverages AI to expedite the extraction of biological insights from scientific literature, significantly reducing processing time while maintaining high accuracy.

by Luisa Crawford
Apr 11, 2025

deepseek

Revolutionizing Antibody Development: AlphaBind Leverages NVIDIA and AWS

AlphaBind, developed by A-Alpha Bio, employs NVIDIA and AWS technologies to enhance antibody-antigen binding predictions, aiming to revolutionize biologics development.

by Joerg Hiller
Dec 04, 2024

deepseek

NVIDIA: EvolutionaryScale Unveils ESM3 Generative AI Model for Protein Design

EvolutionaryScale launches ESM3, an advanced AI model for protein design, leveraging NVIDIA's H100 GPUs to accelerate biological research.

by Joerg Hiller
Jun 25, 2024

DEEPSEEK

NVIDIA NIM Enhances Curation of Biological Insights with AI

Revolutionizing Antibody Development: AlphaBind Leverages NVIDIA and AWS

NVIDIA: EvolutionaryScale Unveils ESM3 Generative AI Model for Protein Design

Trending topics